|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits with banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing time deposits | ||||||||||||||||||||
| Securities available for sale, at fair value (amortized cost $424,888 and $432,167, respectively) | ||||||||||||||||||||
| Securities held to maturity, at amortized cost (fair value $5,542 and $5,243, respectively) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $10,714 ($10,108 in 2025) | ||||||||||||||||||||
| Federal Home Loan Bank and other stock, at cost | ||||||||||||||||||||
| Foreclosed real estate | ||||||||||||||||||||
| Premises and equipment | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Cash value of life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances - Federal Home Loan Bank ("FHLB") | ||||||||||||||||||||
| Borrowed funds - Bank Term Funding Program ("BTFP") | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Preferred stock of $.01 par value per share Authorized 1,000,000 shares; none issued | ||||||||||||||||||||
| Common stock of $.01 par value per share Authorized 7,500,000 shares; issued 3,814,543 shares (3,810,883 in 2025); outstanding 3,345,245 (3,341,871 in 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings-substantially restricted | ||||||||||||||||||||
| Unearned stock compensation | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Less treasury stock, at cost - 469,298 shares (469,012 in 2025) | ||||||||||||||||||||
| Total First Capital, Inc. stockholders' equity | ||||||||||||||||||||
| Noncontrolling interest in subsidiary | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
